AM630 is an inverse agonist at the human cannabinoid CB1 receptor

被引：47
作者：
Landsman, RS
Makriyannis, A
Deng, HF
Consroe, P
Roeske, WR
Yamamura, HI [1 ]
机构：
[1] Univ Arizona, Hlth Sci Ctr, Coll Med, Dept Pharmacol, Tucson, AZ 85724 USA
[2] Univ Arizona, Hlth Sci Ctr, Dept Pharmacol & Toxicol, Tucson, AZ 85724 USA
[3] Univ Arizona, Hlth Sci Ctr, Dept Biochem, Tucson, AZ 85724 USA
[4] Univ Arizona, Hlth Sci Ctr, Dept Med, Tucson, AZ 85724 USA
[5] Univ Arizona, Hlth Sci Ctr, Dept Psychiat, Tucson, AZ 85724 USA
[6] Univ Arizona, Hlth Sci Ctr, Program Neurosci, Tucson, AZ 85724 USA
[7] Univ Connecticut, Sch Pharm, Storrs, CT 06269 USA
来源：
LIFE SCIENCES | 1998年 / 62卷 / 09期
关键词：
human cannabinoid CB1 receptor; inverse agonism; AM630; WIN 55,212-2; GTP gamma S; CHO cells; inverse agonist; negative intrinsic activity;
D O I：
10.1016/S0024-3205(97)01187-9
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
The present investigation examines WIN 55,212-2 and AM630 at the cloned human cannabinoid CB1, receptor stably expressed in Chinese hamster ovary (CHO) cells. The effect of various concentrations of WIN 55,212-2 and AM630 on basal [S-35]GTP gamma S binding to cell membranes was determined. WIN 55,212-2 (100 mu M) stimulated basal [S-35]GTP gamma S binding 77.9% with an EC50 value of 0.36 mu M. Conversely, AM630 (100 mu M) inhibited basal [S-35]GTP gamma S binding by 20.9% with an EC50 value of 0.90 mu M These results show that WIN 55,212-2 is an agonist and AM630 is an inverse agonist in this system. (C) 1998 Elsevier Science Inc.
引用
收藏
页码：PL109 / PL113
页数：5
相关论文
共 50 条
[41]   Differential signalling in human cannabinoid CB1 receptors and their splice variants in autaptic hippocampal neurones [J].
Straiker, Alex ;
Wager-Miller, Jim ;
Hutchens, Jacqueline ;
Mackie, Ken .
BRITISH JOURNAL OF PHARMACOLOGY, 2012, 165 (08) :2660-2671
[42]   Synthesis and SAR of 1,4,5,6-tetrahydropyridazines as potent cannabinoid CB1 receptor antagonists [J].
Lange, Jos H. M. ;
den Hartog, Arnold P. ;
van der Neut, Martina A. W. ;
van Vliet, Bernard J. ;
Kruse, Chris G. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (19) :5675-5678
[43]   Pharmacological characterization of the cannabinoid CB1 receptor PET ligand ortholog, [3H]MePPEP [J].
Suter, Todd M. ;
Chesterfield, Amy K. ;
Bao, Chun ;
Schaus, John M. ;
Krushinski, Joseph H. ;
Statnick, Michael A. ;
Felder, Christian C. .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 649 (1-3) :44-50
[44]   Expression of the cannabinoid system in muscle: effects of a high-fat diet and CB1 receptor blockade [J].
Crespillo, Ana ;
Suarez, Juan ;
Bermudez-Silva, Francisco J. ;
Rivera, Patricia ;
Vida, Margarita ;
Alonso, Monica ;
Palomino, Ana ;
Lucena, Miguel A. ;
Serrano, Antonia ;
Perez-Martin, Margarita ;
Macias, Manuel ;
Fernandez-Llebrez, Pedro ;
Rodriguez de Fonseca, Fernando .
BIOCHEMICAL JOURNAL, 2011, 433 :175-185
[45]   Structural and pharmacological analysis of O-2050, a putative neutral cannabinoid CB1 receptor antagonist [J].
Wiley, Jenny L. ;
Breivogel, Christopher S. ;
Mahadevan, Anu ;
Pertwee, Roger G. ;
Cascio, Maria Grazia ;
Bolognini, Daniele ;
Huffman, John W. ;
Walentiny, D. Matthew ;
Vann, Robert E. ;
Razdan, Raj K. ;
Martin, Billy R. .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 651 (1-3) :96-105
[46]   Relationships between ligand affinities for the cerebellar cannabinoid receptor CB1 and the induction of GDP GTP exchange [J].
Kearn, CS ;
Greenberg, MJ ;
DiCamelli, R ;
Kurzawa, K ;
Hillard, CJ .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (06) :2379-2387
[47]   Overcoming the Psychiatric Side Effects of the Cannabinoid CB1 Receptor Antagonists: Current Approaches for Therapeutics Development [J].
Thuy Nguyen ;
Thomas, Brian F. ;
Zhang, Yanan .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2019, 19 (16) :1418-1435
[48]   Current evidence supporting a role of cannabinoid CB1 receptor (CB1R) antagonists as potential pharmacotherapies for drug abuse disorders [J].
Beardsley, PM ;
Thomas, BF .
BEHAVIOURAL PHARMACOLOGY, 2005, 16 (5-6) :275-296
[49]   Effects of CB1 cannabinoid receptor activation on cerebellar granule cell nitric oxide synthase activity [J].
Hillard, CJ ;
Muthian, S ;
Kearn, CS .
FEBS LETTERS, 1999, 459 (02) :277-281
[50]   PET Imaging Studies in Rhesus Monkey with the Cannabinoid-1 (CB1) Receptor Ligand [11C]CB-119 [J].
Hamill, Terence G. ;
Lin, Linus S. ;
Hagmann, William ;
Liu, Ping ;
Jewell, James ;
Sanabria, Sandra ;
Eng, WaiSi ;
Ryan, Christine ;
Fong, Tung M. ;
Connolly, Brett ;
Vanko, Amy ;
Hargreaves, Richard ;
Goulet, Mark T. ;
Burns, H. Donald .
MOLECULAR IMAGING AND BIOLOGY, 2009, 11 (04) :246-252
12345